312 related articles for article (PubMed ID: 16327817)
21. Ursodeoxycholic acid therapy in primary biliary cirrhosis.
Podda M; Crosignani A; Battezzati PM; Quagliuolo M; Valsania C; Invernizzi P; Zuin M
Ital J Gastroenterol; 1996; 28(2):114-7. PubMed ID: 8782007
[TBL] [Abstract][Full Text] [Related]
22. A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre.
Floreani A; Caroli D; Variola A; Rizzotto ER; Antoniazzi S; Chiaramonte M; Cazzagon N; Brombin C; Salmaso L; Baldo V
Liver Int; 2011 Mar; 31(3):361-8. PubMed ID: 21059170
[TBL] [Abstract][Full Text] [Related]
23. Ursodeoxycholic acid for primary biliary cirrhosis.
Lindor KD; Poupon R; Poupon R; Heathcote EJ; Therneau T
Lancet; 2000 Feb; 355(9204):657-8. PubMed ID: 10697011
[No Abstract] [Full Text] [Related]
24. [Efficacy of combined use of ursodeoxycholic acid and heptral in the treatment of primary biliary cirrhosis].
Avezov SA; Mansurova FKh
Klin Med (Mosk); 2004; 82(2):46-9. PubMed ID: 15106512
[TBL] [Abstract][Full Text] [Related]
25. Safe use of ursodeoxycholic acid in a breast-feeding patient with primary biliary cirrhosis.
Vítek L; Zelenková M; Brůha R
Dig Liver Dis; 2010 Dec; 42(12):911-2. PubMed ID: 20619755
[No Abstract] [Full Text] [Related]
26. The ursodeoxycholic acid story in primary biliary cirrhosis.
Lim AG; Jazrawi RP; Northfield TC
Gut; 1995 Sep; 37(3):301-4. PubMed ID: 7590420
[No Abstract] [Full Text] [Related]
27. Eosinophils and primary biliary cirrhosis-stoking the fire?
Neuberger J
Hepatology; 1999 Jul; 30(1):335-7. PubMed ID: 10385676
[No Abstract] [Full Text] [Related]
28. Results of long-term ursodiol treatment for patients with primary biliary cirrhosis.
Jorgensen R; Angulo P; Dickson ER; Lindor KD
Am J Gastroenterol; 2002 Oct; 97(10):2647-50. PubMed ID: 12385454
[TBL] [Abstract][Full Text] [Related]
29. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
[TBL] [Abstract][Full Text] [Related]
30. Ursodeoxycholic acid for primary biliary cirrhosis.
Drug Ther Bull; 1999 Apr; 37(4):30-2. PubMed ID: 10563063
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
Babatin MA; Sanai FM; Swain MG
Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
[TBL] [Abstract][Full Text] [Related]
32. Comment on biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
Walker LJ; Newton J; Jones DE; Bassendine MF
Hepatology; 2009 Jan; 49(1):337-8; author reply 338. PubMed ID: 19035342
[No Abstract] [Full Text] [Related]
33. [Treatment of primary biliary cirrhosis].
Szalay F
Orv Hetil; 2003 Sep; 144(36):1787-8. PubMed ID: 14579676
[No Abstract] [Full Text] [Related]
34. Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis.
Dimoulios P; Kolios G; Notas G; Matrella E; Xidakis C; Koulentaki M; Tsagarakis N; Kouroumalis A; Kouroumalis E
Aliment Pharmacol Ther; 2005 Feb; 21(3):227-34. PubMed ID: 15691296
[TBL] [Abstract][Full Text] [Related]
35. The timing of liver transplantation in primary biliary cirrhosis.
Angulo P; Dickson ER
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):657-68. PubMed ID: 10976021
[TBL] [Abstract][Full Text] [Related]
36. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
Linares Rodríguez A
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
[No Abstract] [Full Text] [Related]
37. [Interview: questions to Professor Raoul Poupon].
Poupon R
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):333-7. PubMed ID: 12700521
[No Abstract] [Full Text] [Related]
38. Ursodeoxycholic acid for primary biliary cirrhosis: lesson for the future?
Gluud C; Christensen E
J Hepatol; 2001 May; 34(5):787-8. PubMed ID: 11434634
[No Abstract] [Full Text] [Related]
39. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
Silveira MG; Lindor KD
Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
[TBL] [Abstract][Full Text] [Related]
40. Clinical studies with silymarin: fibrosis progression is the end point.
Schuppan D; Hahn EG
Hepatology; 2001 Feb; 33(2):483-4. PubMed ID: 11172360
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
